Sylvester Comprehensive Cancer Center Researcher Presents Phase 1 Trial for Neuroendocrine Tumors at ASCO
May 21, 2026
May 21, 2026
MIAMI, Florida, May 21 -- The University of Miami Miller School of Medicine posted the following news:
* * *
Sylvester Comprehensive Cancer Center Researcher Presents Phase 1 Trial for Neuroendocrine Tumors at ASCO
Summary
* A Sylvester researcher will present a phase I clinical trial combining immunotherapy and an oncolytic virus at the ASCO annual meeting.
* The study targets aggressive neuroendocrine tumors that often resist s . . .
* * *
Sylvester Comprehensive Cancer Center Researcher Presents Phase 1 Trial for Neuroendocrine Tumors at ASCO
Summary
* A Sylvester researcher will present a phase I clinical trial combining immunotherapy and an oncolytic virus at the ASCO annual meeting.
* The study targets aggressive neuroendocrine tumors that often resist s . . .